Health & Wellness Personalis Inc share price jumps 50% on deals with Merck and Moderna These developments are a validation of Personalis' business strategy and its potential in the genomics and cancer treatment space Joseph MortonDecember 19, 2024
AI and Autonomy NetraMark demonstrates efficacy of AI to help with clinical trials AI analyzes huge amounts of data, finds patterns, and makes decisions on its own Joseph MortonMarch 11, 2024